HUSSAIN IQBAL J (General Counsel) sold 40.9% of their position (39.96K shares) of CENTESSA PHARMACEUTICALS PLC on the open market
Open‑market sale worth $1.00M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Ordinary Shares
Shares
−1.01K
Price / share
$25.01
Trade value
$25.26K
% of position
Ordinary Shares
Shares
−7.78K
Price / share
$24.57
Trade value
$191.15K
% of position
Ordinary Shares
Shares
−38.95K
Price / share
$25.15
Trade value
$979.66K
% of position
Ordinary Shares
Shares
+40K
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
+20K
Price / share
—
Trade value
—
% of position
Net shares
+12.26K
Net value
-$1.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/30/2026 | S · Sale | −1.01K | $25.01 | $25.26K | 1.0% | 105.39K | 104.38K |
| Ordinary Shares Direct | 2/1/2026 | F · Tax Withholding | −7.78K | $24.57 | $191.15K | 7.5% | 104.38K | 96.60K |
| Ordinary Shares Direct | 2/2/2026 | S · Sale | −38.95K | $25.15 | $979.66K | 40.3% | 96.60K | 57.65K |
| Ordinary Shares Direct | 2/2/2026 | A · Award | +40K | — | — | 69.4% | 57.65K | 97.64K |
| Ordinary Shares Direct | 2/2/2026 | A · Award | +20K | — | — | 20.5% | 97.64K | 117.64K |
| Total | +12.26K | -$1.20M | ||||||
Share Option (right to buy)
Ordinary Shares
160K shares
Shares
+160K
Strike price
25.19
Held after
160K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares160K shares | 2/2/2026 | A · Award | +160K | 25.19 | — | 160K |
Ordinary Shares
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 5.50K | Indirect |
| Total | 5.50K | 5.50K indirect |